Tag: Bureau of Competition

By a 3-1-1 vote, the Federal Trade Commission today closed its investigation into Genzyme Corporation's (Genzyme) 2001 acquisition of Novazyme Pharmaceuticals, Inc. (Novazyme). At the time of its...

The Federal Trade Commission has published a notice describing the types of agreements that brand-name pharmaceutical and generic drug manufacturers must file with the FTC and the U.S. Department of...

In an initial decision filed on November 25, 2003, and announced today, Administrative Law Judge (ALJ) D. Michael Chappell dismissed a complaint brought earlier this year by the Commission that...

A Houston, Texas-based physicians’ group has agreed to settle FTC charges that it increased costs for consumers, employers, and health plans by fixing prices jointly in contract negotiations with...

The Federal Trade Commission has issued its staff report to Congress providing new information from the staff’s case studies about slotting allowances paid to certain retailers in certain geographic...

Testifying today on behalf of the Federal Trade Commission before the U.S. House of Representatives Subcommittee on Commerce, Trade, Energy, and Consumer Protection of the Committee on Energy and...

The Federal Trade Commission today announced it has settled separate allegations of illegal anticompetitive conduct by associations in Minnesota and Iowa. The proposed consent orders settle charges...

The Federal Trade Commission has issued a unanimous policy statement on the use of monetary equitable remedies such as disgorgement and restitution in competition cases – specifically, those involving...

The Federal Trade Commission today announced a proposed consent agreement with a Baton Rouge, Louisiana-based independent practice association (IPA), the three orthopedic practices whose doctors are...

Nestlé S.A. and Dreyer's Grand Ice Cream Inc. have agreed to divest three of Dreyer's brands and Nestlé's distribution assets to settle Federal Trade Commission charges that their merger would lessen...